CE vs DAWN · rev $10.28B vs rev $131.2M
Celanese Corporation (CE) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
CE currently screens at market cap $5.92B. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the CE and DAWN stock pages for the full models.
Not investment advice.